TAM
CPRX

Tocqueville Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Tocqueville Asset Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,594
Closed -$106K – 710
2021
Q4 		$106K Sell
15,594
-44
-0.3% -$289 ﹤0.01% 727
2021
Q3 		$83K Hold
15,638
– – ﹤0.01% 720
2021
Q2 		$90K Sell
15,638
-37
-0.2% -$191 ﹤0.01% 730
2021
Q1 		$72K Buy
+15,675
New +$62.3K ﹤0.01% 714

Other funds holding CPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Tocqueville Asset Management's CPRX Position: Q1 2022 in Review

Tocqueville Asset Management sold out of Catalyst Pharmaceutical (CPRX) in Q1 2022, closing a stake of 15,594 shares — an estimated $106K sold.

Tocqueville Asset Management first reported a position in CPRX in Q1 2021 and held it in 4 quarters. The position peaked at $106K in Q4 2021. 187 funds tracked by Wall St. Rank hold CPRX as of Q1 2022.

  • Tocqueville Asset Management reported no remaining Catalyst Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • Tocqueville Asset Management sold 15,594 Catalyst Pharmaceutical shares in Q1 2022, an estimated $106K.
  • Tocqueville Asset Management first reported a position in Catalyst Pharmaceutical in Q1 2021 and held it in 4 quarters.
  • Tocqueville Asset Management's Catalyst Pharmaceutical position peaked at $106K in Q4 2021.
  • 187 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2022.

Based on Tocqueville Asset Management's 13F filing for Q1 2022, filed 16 May 2022.